Page last updated: 2024-08-18

phenformin and ER-Negative PR-Negative HER2-Negative Breast Cancer

phenformin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ang, WH; Babak, MV; Balyasnikova, IV; Casini, A; Chang, MR; Chong, KR; Heffeter, P; Kushnarev, V; Lim, ZC; Meier-Menches, SM; Rapta, P; Reichert, L; Tang, HM; Yap, JY; Zannikou, M	1

Other Studies

1 other study(ies) available for phenformin and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs. Angewandte Chemie (International ed. in English), 2021, 06-07, Volume: 60, Issue:24 Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Coordination Complexes; Drug Evaluation, Preclinical; Energy Metabolism; Gold; Humans; Metformin; Mice; Molecular Conformation; Phenformin; Prodrugs; Transplantation, Heterologous; Triple Negative Breast Neoplasms	2021

Article

Year

Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs.

Angewandte Chemie (International ed. in English), 2021, 06-07, Volume: 60, Issue:24

Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Coordination Complexes; Drug Evaluation, Preclinical; Energy Metabolism; Gold; Humans; Metformin; Mice; Molecular Conformation; Phenformin; Prodrugs; Transplantation, Heterologous; Triple Negative Breast Neoplasms

2021